Under this agreement, lpca will grant to Omexa a non-exclusive right to research, develop, manufacture and market an anti-cancer biosimilar for the global market
Under the arrangement, Dr. Reddy's will have exclusive rights to promote and distribute Sanofi's vaccine brands Hexaxim, Pentaxim, Tetraxim, Menactra, FluQuadri, Adacel and Avaxim 80U
Versavo is the first Dr. Reddy's biosimilar product to be approved and launched in the UK
Both organisations enter into a long- term collaboration to expand patient access in India
New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million vials per day
Grand opening of the joint venture between Evonik China and Shandong Vland Biotech in Qingdao, China
This partnership marks a significant step for the Company towards establishing renewable energy power generation using hybrid open excess through solar and wind sources
The WHO GMP approved vertically integrated ONCOLOGY unit of SAKAR has been selling products nationally since few quarters
Sadhana Nitro Chem's plant is the second plant in the world to manufacture pAP from Nitrobenzene
Connecting new production and consumption areas of chilled food by low-carbon transportation services
Subscribe To Our Newsletter & Stay Updated
